ENAH and cancer: The development of actin modulating drugs is a field of interest in cancer and it is becoming evident that actin-binding proteins (ABPs) may represent a target to regulate actin polymerization and depolymerization, as reported for the small-molecule inhibitors of Ena/VASP EVH1 interaction, able to impair invasion and extravasation of breast cancer cells [42].